<VariationArchive VariationID="573472" VariationName="NM_152594.3(SPRED1):c.234dup (p.Asp79fs)" VariationType="Duplication" Accession="VCV000573472" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="573217" VariationID="573472">
      <GeneList>
        <Gene Symbol="SPRED1" FullName="sprouty related EVH1 domain containing 1" GeneID="161742" HGNC_ID="HGNC:20249" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q14</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="38252836" stop="38357249" display_start="38252836" display_stop="38357249" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="38545051" stop="38649449" display_start="38545051" display_stop="38649449" Strand="+" />
          </Location>
          <OMIM>609291</OMIM>
          <Haploinsufficiency last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SPRED1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SPRED1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_152594.3(SPRED1):c.234dup (p.Asp79fs)</Name>
      <CanonicalSPDI>NC_000015.10:38322261:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>15q14</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="38322261" stop="38322262" display_start="38322261" display_stop="38322262" variantLength="1" positionVCF="38322261" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="38614462" stop="38614463" display_start="38614462" display_stop="38614463" variantLength="1" positionVCF="38614462" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>D79fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.38322267dup" Assembly="GRCh38">
            <Expression>NC_000015.10:g.38322267dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.38614468dup" Assembly="GRCh37">
            <Expression>NC_000015.9:g.38614468dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008980.1" sequenceAccession="NG_008980" sequenceVersion="1" change="g.74417dup">
            <Expression>NG_008980.1:g.74417dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152594.3" sequenceAccession="NM_152594" sequenceVersion="3" change="c.234dup" MANESelect="true">
            <Expression>NM_152594.3:c.234dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_689807.1" sequenceAccession="NP_689807" sequenceVersion="1" change="p.Asp79fs">
            <Expression>NP_689807.1:p.Asp79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_152594.2" sequenceAccession="NM_152594" sequenceVersion="2" change="c.234dupA">
            <Expression>NM_152594.2:c.234dupA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1566867209" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_152594.3(SPRED1):c.234dup (p.Asp79fs) AND Legius syndrome" Accession="RCV000695156" Version="4">
        <ClassifiedConditionList TraitSetID="460">
          <ClassifiedCondition DB="MedGen" ID="C1969623">Legius syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-05-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_152594.3(SPRED1):c.234dup (p.Asp79fs) AND Cardiovascular phenotype" Accession="RCV004025231" Version="1">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-04" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2018-10-10" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17704776</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5389" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Legius syndrome</ElementValue>
                <XRef ID="Legius+syndrome/4153" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012669" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurofibromatosis type 1 like syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPRED1</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">NFLS</ElementValue>
                <XRef Type="MIM" ID="611431" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10714" />
                <XRef ID="10714" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Legius syndrome is characterized by multiple caf√© au lait macules without neurofibromas or other tumor manifestations of neurofibromatosis type 1 (NF1). Additional clinical manifestations reported commonly include intertriginous freckling, lipomas, macrocephaly, and learning disabilities / attention-deficit/hyperactivity disorder (ADHD) / developmental delays. Current knowledge of the natural history of Legius syndrome is based on the clinical manifestations of fewer than 300 individuals with a molecularly confirmed diagnosis; better delineation of the clinical manifestations and natural history of Legius syndrome will likely occur as more affected individuals are identified.</Attribute>
                <XRef ID="NBK47312" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000509019" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551630" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501087" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509021" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500881" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562238" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502542" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551628" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562242" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000521399" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569525" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568167" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528461" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000568134" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520039" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562237" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506067" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514608" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561717" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945555</ID>
                <ID Source="BookShelf">NBK47312</ID>
              </Citation>
              <XRef ID="137605" DB="Orphanet" />
              <XRef ID="C1969623" DB="MedGen" />
              <XRef ID="MONDO:0012669" DB="MONDO" />
              <XRef Type="MIM" ID="611431" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1595416" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="4323732|MedGen:C1969623" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000823638" DateUpdated="2024-02-14" DateCreated="2018-10-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17704776</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in SPRED1 are known to be pathogenic (PMID: 17704776). This variant has not been reported in the literature in individuals with SPRED1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp79Argfs*5) in the SPRED1 gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPRED1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.38614462_38614463insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1969623" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7611112" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="a9571960|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004085721" DateUpdated="2024-05-01" DateCreated="2023-10-28" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.234dupA (p.D79Rfs*5) alteration, located in exon 3 (coding exon 3) of the SPRED1 gene, consists of a duplication of A at position 234, causing a translational frameshift with a predicted alternate stop codon after 5 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SPRED1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_152594.2:c.234dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough091523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7611112" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1595416" TraitType="Disease" MappingType="XRef" MappingValue="C1969623" MappingRef="MedGen">
        <MedGen CUI="C1969623" Name="Legius syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

